Suchergebnisse - "Klag, Thomas"

1

Wirkmechanismen und Wirkung von Biologika und JAK-Inhibitoren bei CED

von: Klag, Thomas

2019, in: Gastronews

Wird geladen...
2

Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy

von: Klag, Thomas

2013, in: Zeitschrift für Kardiologie

Wird geladen...
3

Human Endogenous Retroviruses and Residues of Ancient Times - are Differentially Expressed in Crohǹs Disease

von: Klag, Thomas

2017, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
4

Hepatitis C “true” late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy

von: Klag, Thomas

2017, in: Identification of the antigenic region of

Wird geladen...
5

Leriche’s syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome

von: Klag, Thomas

2011, in: Annals of hematology

Wird geladen...
6

Tu1241 - Clinical Experience with Ustekinumab in Selected Crohns Disease Patients

von: Saman, Sadik

2018, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
7

Enterocutaneous fistula in severely active Crohn’s disease: preoperative anti-TNF alpha treatment to limit bowel resection—report of a case

von: Wilhelm, Peter

2018, in: International journal of colorectal disease

Wird geladen...
8

Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance

von: Ruf, Benjamin

2022, in: International journal of gastrointestinal cancer

Wird geladen...
9

Tu1771 - Crohns Disease Patients Isolated Classical Monocytes are Characterized by Reduced Secretion of Wnt-Ligands Affecting Paneth Cell Antimicrobial Host Defense

von: Armbruster, Nicole S.

2018, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
10

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity

von: Härtel, Nicolai

2011, in: Journal of cancer research and clinical oncology

Wird geladen...
11

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib

von: La Rosée, Paul

2013, in: Annals of hematology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!